Catheter Precision (VTAK) Accumulated Depreciation & Amortization (2017 - 2025)
Catheter Precision (VTAK) has disclosed Accumulated Depreciation & Amortization for 9 consecutive years, with $152000.0 as the latest value for Q3 2025.
- On a quarterly basis, Accumulated Depreciation & Amortization rose 97.4% to $152000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $152000.0, a 97.4% increase, with the full-year FY2024 number at $97000.0, up 203.12% from a year prior.
- Accumulated Depreciation & Amortization was $152000.0 for Q3 2025 at Catheter Precision, up from $135000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.5 million in Q2 2021 to a low of $15000.0 in Q2 2023.
- A 5-year average of $901428.6 and a median of $87000.0 in 2024 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 98.97% in 2023, then soared 286.67% in 2024.
- Catheter Precision's Accumulated Depreciation & Amortization stood at $2.8 million in 2021, then rose by 2.28% to $2.9 million in 2022, then plummeted by 98.9% to $32000.0 in 2023, then skyrocketed by 203.12% to $97000.0 in 2024, then skyrocketed by 56.7% to $152000.0 in 2025.
- Per Business Quant, the three most recent readings for VTAK's Accumulated Depreciation & Amortization are $152000.0 (Q3 2025), $135000.0 (Q2 2025), and $97000.0 (Q4 2024).